Vaccination News

There were increases in rare pediatric intracranial infections over the past 3 years that coincided with notable spikes in respiratory viruses, although the infections remained rare, according to two reports published Thursday in MMWR.

A recent study of trends in HPV vaccine hesitancy found that the number of parents citing safety concerns as a reason not to vaccinate their children has increased.

The FDA has fully approved Paxlovid to treat COVID-19 in adults after the antiviral pill was first granted emergency use authorization in December 2021.

A pentavalent vaccine against Neisseria meningitidis was shown to be safe and effective in a phase 3 trial conducted among children and young adults in Africa’s meningitis belt, researchers reported in The New England Journal of Medicine.

Gavi, the Vaccine Alliance forecasted that the global supply of oral cholera vaccine is likely to remain limited through 2025 if current outbreak trends continue.

President Joe Biden remarked on the “hidden epidemic” of viral hepatitis — which has infected more than 3.2 million Americans, many of whom are not aware of their infection — in a proclamation for Hepatitis Testing Day on May 19.

According to HHS, many of the more than 3.2 million people in the United States with hepatitis B or C are not aware of their infection, raising their risk for severe complications or death and risking further spread of the viruses.

An FDA advisory committee on Thursday voted in favor of a respiratory syncytial virus vaccine that would be administered to pregnant people to protect their infants.

The Jynneos vaccine was up to 86% effective at preventing mpox in people who received two doses during the United States outbreak, according to three studies published Thursday.

The National Institute of Allergy and Infectious Diseases announced this week that it has started enrolling participants in a phase 1 trial testing an experimental universal influenza vaccine that uses a messenger RNA platform.